Fred Telling, Director at ORAGENICS INC (OGEN), bought 10,084 shares at $0.29 ($3K) on 2022-06-17, disclosed to the SEC on 2022-06-21.
Open-market purchase of $3k OGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| OGEN | SELL | 2024-12-09 | $1K | — | Filing → |
| OGEN | SELL | 2023-12-01 | $12K | — | Filing → |
| OGEN | BUY | 2022-05-25 | $24K | — | Filing → |